FOXO4-DRI

FOXO4-p53 interaction-disrupting peptide, 10mg vial

$180.00

Format Lyophilized powder, vial

Purity ≥99% (HPLC)

CAS 2460055-10-9

Documentation COA by request

This product is intended for in-vitro and pre-clinical research purposes only. It is not intended for human consumption, nor for use as a drug, food additive, or household chemical. These statements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. By purchasing, the customer acknowledges all risks of handling and distribution, and agrees to indemnify Sokai Sciences against any claims arising from misuse.

FAQ

Common questions

What is FOXO4-DRI?+

A synthetic peptide designed to disrupt the FOXO4-p53 protein interaction inside senescent cells.

What field of research is FOXO4-DRI associated with?+

Senescent-cell (senolytic) research literature.

What CAS number identifies FOXO4-DRI?+

2460055-10-9.

About

About FOXO4-DRI

FOXO4-DRI is a synthetic peptide designed to disrupt the interaction between the FOXO4 and p53 proteins inside senescent cells — a mechanism referenced in senescent-cell (senolytic) research literature. Synthesized to ≥99% purity (HPLC); certificate of analysis available per batch. For laboratory research use only.

You may also want

#cellular-aging AICAR Sold out

Cellular Aging

AMPK-activating nucleoside analog, 50mg vial

Lyophilized powder, vial · 1 size

#cellular-aging Epithalon

Cellular Aging

Synthetic AEDG tetrapeptide, 5mg vial

Lyophilized powder, vial · 3 sizes

#cellular-aging MOTS-c

Cellular Aging

Mitochondrial-derived 16-aa peptide, 10mg vial

Lyophilized powder, vial · 2 sizes